JURÁČEK, Jaroslav, Marie BOUDNÁ, Michal STANÍK, Michaela RUČKOVÁ, Karolína TRACHTOVÁ, Hana MALČÍKOVÁ, Eva LŽIČAŘOVÁ, Dominik A BARTH, Martin PICHLER and Ondřej SLABÝ. A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer. Prostate. HOBOKEN: WILEY, 2023, vol. 83, No 4, p. 340-351. ISSN 0270-4137. Available from: https://dx.doi.org/10.1002/pros.24466.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A tissue miRNA expression pattern is associated with disease aggressiveness of localized prostate cancer
Authors JURÁČEK, Jaroslav (203 Czech Republic, belonging to the institution), Marie BOUDNÁ (203 Czech Republic, belonging to the institution), Michal STANÍK (703 Slovakia), Michaela RUČKOVÁ (203 Czech Republic, belonging to the institution), Karolína TRACHTOVÁ (203 Czech Republic, belonging to the institution), Hana MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Eva LŽIČAŘOVÁ (203 Czech Republic), Dominik A BARTH, Martin PICHLER and Ondřej SLABÝ (203 Czech Republic, belonging to the institution).
Edition Prostate, HOBOKEN, WILEY, 2023, 0270-4137.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.800 in 2022
RIV identification code RIV/00216224:14110/23:00134724
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1002/pros.24466
UT WoS 000893769400001
Keywords in English disease aggressiveness; microRNA; prognosis; prostate cancer; prostate specific antigen
Tags 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 27/3/2024 07:11.
Abstract
BackgroundProstate cancer (PCa) is a heterogeneous malignancy with high variability in clinical course. Insufficient stratification according to the aggressiveness at the time of diagnosis causes unnecessary or delayed treatment. Current stratification systems are not effective enough because they are based on clinical, surgical or biochemical parameters, but do not take into account molecular factors driving PCa cancerogenesis. MicroRNAs (miRNAs) are important players in molecular pathogenesis of PCa and could serve as valuable biomarkers for the assessment of disease aggressiveness and its prognosis. MethodsIn the study, in total, 280 PCa patients were enrolled. The miRNA expression profiles were analyzed in FFPE PCa tissue using the miRCURY LNA miRNA PCR System. The expression levels of candidate miRNAs were further verified by two-level validation using the RT-qPCR method and evaluated in relation to PCa stratification reflecting the disease aggressiveness. ResultsMiRNA profiling revealed 172 miRNAs dysregulated between aggressive (ISUP 3-5) and indolent PCa (ISUP 1) (p < 0.05). In the training and validation cohort, miR-15b-5p and miR-106b-5p were confirmed to be significantly upregulated in tissue of aggressive PCa when their level was associated with disease aggressiveness. Furthermore, we established a prognostic score combining the level of miR-15b-5p and miR-106b-5p with serum PSA level, which discriminated indolent PCa from an aggressive form with even higher analytical parameters (AUC being 0.9338 in the training set and 0.8014 in the validation set, respectively). The score was also associated with 5-year biochemical progression-free survival (bPFS) of PCa patients. ConclusionsWe identified a miRNA expression pattern associated with disease aggressiveness in prostate cancer patients. These miRNAs may be of biological interest as the focus can be also set on their specific role within the molecular pathology and the molecular mechanism that underlies the aggressivity of prostate cancer.
Links
NV18-03-00360, research and development projectName: Využití močových/tkáňových mikroRNA k navýšení specificity PSA a odlišení indolentní a agresivní formy karcinomu prostaty
Investor: Ministry of Health of the CR, Usage of urinary/tissue microRNAs to increase PSA specificity and distinguish between indolent and aggressive forms of prostate cancer
PrintDisplayed: 17/7/2024 09:35